Urinary excretion kinetics of 177Lu-PSMA

被引：0
|
作者：
de Bakker, M. [1 ]
Dominicus, N. [1 ]
Meeuwis, A. [1 ]
Janssen, M. J. R. [1 ]
Konijnenberg, M. W. [1 ,2 ]
Nagarajah, J. [1 ]
Peters, S. M. B. [1 ]
机构：
[1] Radboudumc, Nijmegen, Netherlands
[2] Erasmus MC, Rotterdam, Netherlands
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2022年 / 49卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-102
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [21] Effect of External Cooling on 177Lu-PSMA Uptake by the Parotid Glands
    Yilmaz, Burcak
    Nisli, Serap
    Ergul, Nurhan
    Gursu, Riza Umar
    Acikgoz, Ozgur
    Cermik, Tevfik Fikret
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (10) : 1388 - 1393
  • [22] Feasibility of 177Lu-PSMA Administration as Outpatient Procedure for Prostate Cancer
    Zagni, Federico
    Vetrone, Luigia
    Farolfi, Andrea
    Vadala, Maria
    Rizzini, Elisa Lodi
    Golemi, Arber
    Strigari, Lidia
    Fanti, Stefano
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (12) : 1848 - 1849
  • [23] Harmonisation of Serial 177Lu-PSMA SPECT/CT Images in Patients with Metastatic Castrate-Resistant Prostate Cancer Treated with 177Lu-PSMA-617: A Prospective Multicentre 177Lu-PSMA SPECT/CT harmonisation (ENZA-p)
    Ayati, N.
    Hioki, T.
    van Oorschodt, J. C. J.
    McGill, G.
    Marquis, H.
    Francis, R.
    Bailey, D.
    Eslick, E.
    Sandhu, S.
    Davis, I. D.
    Stockler, M.
    Subramaniam, S.
    Crumbaker, M.
    Subhash, V.
    Sharma, S.
    Ayers, M.
    Jackson, P.
    Emmett, L.
    Willowson, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S280 - S281
  • [24] Model Selection Based on Population Fitting at an Example of 177Lu-PSMA Kinetics in Kidneys with a Low Number of Data
    Hardiansyah, Deni
    Riana, Ade
    Kletting, Peter
    Zaid, Nouran
    Beer, Ambros
    Glatting, Gerhard
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [25] Comparison of 68Ga-PSMA and 177Lu-PSMA Total Metabolic Tumor Volume (TMTV) variations for monitoring metastatic castration-resistant prostate cancer in 177Lu-PSMA therapy.
    Boursier, C.
    Zaragori, T.
    Kunsch, J.
    Olivier, P.
    Claudin, M.
    Marie, P.
    Bros, M.
    Bordonne, M.
    Verger, A.
    Karcher, G.
    Imbert, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S361 - S362
  • [26] Radiation levels outside a patient undergoing 177Lu-PSMA radioligand therapy
    Li, Huan
    Liu, Haikuan
    Zhang, Weiyuan
    Lin, Xin
    Li, Zhiling
    Zhuo, Weihai
    JOURNAL OF RADIOLOGICAL PROTECTION, 2024, 44 (02)
  • [27] 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
    Sanli, Yasemin
    Simsek, Duygu Has
    Sanli, Oner
    Subramaniam, Rathan M.
    Kendi, Ayse Tuba
    BIOMEDICINES, 2021, 9 (04)
  • [28] Dosimetric evaluation of the lacrimal glands in patients undergoing therapy with 177Lu-PSMA
    Happel, C.
    Voeller, L.
    Kranert, W. T.
    Groener, D.
    Bockisch, B.
    Ngoc, C. Nguyen
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S102 - S103
  • [29] 177Lu-PSMA for advanced prostate cancer: are we ready to play big?
    Charisma Hehakaya
    Ellen H. M. Moors
    Helena M. Verkooijen
    Diederick E. Grobbee
    Frederik A. Verburg
    Marnix G. E. H. Lam
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2325 - 2328
  • [30] 177Lu-PSMA Therapy for Metastatic Testicular Mixed Germ Cell Tumor
    Has Simsek, Duygu
    Civan, Caner
    Ekenel, Meltem
    Kuyumcu, Serkan
    Sanli, Yasemin
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (05) : 415 - 418
12345